Clozapine use in a forensic population in a New South Wales prison hospital

The Australian and New Zealand Journal of Psychiatry
Adam MartinAnthony Samuels

Abstract

To document and measure various parameters and outcomes in patients prescribed clozapine in a forensic psychiatric setting. A retrospective file review was conducted on patients prescribed clozapine. Parameters and outcomes were recorded and compared against a group prescribed other antipsychotics, matched for sex and diagnosis. Patients prescribed clozapine had higher rates of substance misuse syndromes and comorbidity when compared to patients prescribed other antipsychotics. Clozapine was found to be effective in treatment of psychosis. High rates of adverse effects were noted. Discontinuation of clozapine for a variety of reasons was common. Patients identified as treatment resistant who are prescribed clozapine are often more complex in the pattern of illness and subsequent needs. Clozapine is effective in the treatment of psychosis in this forensic service. Its benefits need to be balanced against the potential for adverse effects and problems ensuring adherence. Regular, objective monitoring of clinical and adverse effects would aid patient safety, clinical decision-making and future research.

References

Feb 1, 1995·The American Journal of Psychiatry·G W ThatcherB Bair
Dec 1, 1994·Neurology·S V Pacia, O Devinsky
May 1, 1994·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·P Toth, F R Frankenburg
Aug 1, 1993·Journal of Clinical Psychopharmacology·J VolavkaP Czobar
Jul 15, 1993·The New England Journal of Medicine·J M AlvirJ A Schaaf
Aug 1, 1997·Journal of Clinical Psychopharmacology·M HummerW W Fleischhacker
Dec 10, 1999·Lancet·J G KilianD S Celermajer
Jun 14, 2000·The Annals of Pharmacotherapy·L Davydov, S R Botts
Sep 22, 2000·Pharmacotherapy·D P Rogers, J K Shramko
Dec 1, 2001·Schizophrenia Research·K N R ChengappaN Schooler
Sep 11, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Jane EdwardsPatrick McGorry
Nov 24, 2004·The Australian and New Zealand Journal of Psychiatry·Jonathan ReindersSally Plever
Jan 12, 2005·Journal of Clinical Psychopharmacology·David B MerrillDonald C Goff
Dec 1, 2003·Irish Journal of Psychological Medicine·Steve MacGillivrayBrian Williams

❮ Previous
Next ❯

Citations

Apr 27, 2012·The Australian and New Zealand Journal of Psychiatry·Elise V GriffithsM Joy Spark
Jun 24, 2017·The Psychiatric Quarterly·Kathleen PatchanDeanna L Kelly
May 24, 2016·International Journal of Evidence-based Healthcare·Kerrie WestawayElizabeth Roughead
Jun 13, 2020·Frontiers in Psychiatry·Christian Farrell, Johann Brink

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Software Mentioned

Global Improv

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.